A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol-Reference-Cited by-同舟云学术

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

Published:2009-08-14 Issue:12 Volume:24 Page:3063-3072
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Human Reproduction

Author:

Devroey P.,Boostanfar R.,Koper N.P.,Mannaerts B.M.J.L.,IJzerman-Boon P.C.,Fauser B.C.J.M.,

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynaecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/24/12/3063/17053582/dep291.pdf

Reference36 articles.

1. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol

2. Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review

3. First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males

4. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follicle-Stimulating Hormone;Pharmaceutical Biotechnology;2024

2. The GnRH antagonist protocol;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

3. Maximizing fertility outcomes in poor ovarian response patients;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

4. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial;Human Reproduction;2023-11-30

5. Conventional ovarian stimulation vs. delayed single dose corifollitropin alfa ovarian stimulation in oocyte donors: a prospective randomized study. Tail trial;Frontiers in Reproductive Health;2023-10-30